Vildagliptin and Metformin Tablets 50/1000 mg Relative to GALVUS MET (50mg/1000 mg) Tablets

Clinical trial NCT06248801 · UNKNOWN

Trial details

NCT number: NCT06248801
Sponsor: Bio-innova Co., Ltd
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Subjects

Start date: 2024-09-05
Primary completion: 2024-10-01
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.